Case report: Alpelisib-induced Stevens–Johnson syndrome

Case report: Alpelisib-induced Stevens–Johnson syndrome

BackgroundAlpelisib is a recently approved treatment for hormone receptor-positive, HER2-negative, PIK3CA-mutated advanced breast cancer. It has been associated with alopecia and rash, but there are no documented cases of Stevens–Johnson Syndrome (SJS) associated with this drug. Here, we detail the...

Full description

Bibliographic Details
Main Authors: Christine Jane Kurian, Akshay Desai, William Rafferty, Ahmed Kamel Abou Hussein
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-09-01
Series:Frontiers in Oncology
Subjects:
breast cancer
metastatic breast cancer
alpelisib
Stevens Johnson syndrome (SJS)
Stevens Johnson Syndrome
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.954027/full

Similar Items

Similar Items